Back to article: Multiple genome analysis of Candida glabrata clinical isolates renders new insights into genetic diversity and drug resistance determinants

FIGURE 6. Comparison of the susceptibility to antifungal azole drugs and caspofungin, at the indicated concentrations, of the C. glabrata KEU100 wild-type strain or derived single mutant strains on YPD agar plates by spot assays. The inoculum was prepared as described in the Materials and methods section. Cell suspensions used to prepare the spots correspond to 1:5 (b) and 1:25 (c) dilutions of the cell suspensions used in (a). The displayed images are representative of at least three independent experiments.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.